Skip to Content

Frequently Searched

Supported by

Tisotumab vedotin-tftv (Tivdak®) Management

Download PQI pdf 1.76MB

Last Updated: December 1, 2024

By: Mitchell Cancer Institute, AL | Johns Hopkins, MD

About this PQI in Action

This PQI in Action is a follow up to the Tisotumab vedotin-tftv (Tivdak®) Management PQI and explores how the medically integrated teams at Mitchell Cancer Institute and Johns Hopkins collaborate and utilize the information found in the PQI as part of their daily practice. This article will discuss how utilizing the Tisotumab vedotin-tftv (Tivdak®) Management PQI elevates patient care.

More About This PQI in Action

Find a PQI

PQI

 PQI: Tisotumab vedotin-tftv (Tivdak®) Management

Last Updated: May 2, 2024